Clinical trial Recruiting at 11 sites Interventional Ages 75 and up

Monitoring opioids and sedatives to prevent organ dysfunction and mortality after surgery

Official title: Prevention of Organ Dysfunction and Mortality by Monitoring the Administration of Opioids and Hypnotics in Patients at High Postoperative Risk: the Opti-Two Study. A Multi-center Controlled Randomized Study.

Run by Centre Hospitalier Universitaire de Saint Etienne · NCT05893030 · Data updated 2026-11-12

This study tests if closely watching pain and sedation levels during surgery can help older patients avoid serious complications and live longer after high-risk operations.

Quick facts

Study typeInterventional
Ages75 Years and up
SexAll
Enrollment1132 (estimated)
SponsorCentre Hospitalier Universitaire de Saint Etienne
Academic / other
Locations20 sites (Amiens and 19 other locations)
StatusRecruiting
StartedOctober 12, 2023
Main results expectedFebruary 2028
Study endsFebruary 2028
Registry record updatedOctober 8, 2026
Trial IDNCT05893030 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients over 75 years old with at least one postoperative risk factor undergoing high-risk surgery.

Probably not a fit

Patients who are younger than 75 or do not have any of the specified postoperative risk factors may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the impact of monitoring sedation and analgesia during high-risk surgeries to reduce intraoperative hypotension, which can lead to increased postoperative complications and mortality. It focuses on patients over 75 years old with specific postoperative risk factors, assessing the combined optimization of hypnotic and opioid agents. The study aims to demonstrate the benefits of this monitoring approach on postoperative organ dysfunction and mortality, building on previous findings that suggest its effectiveness in major abdominal surgeries.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the risk of organ dysfunction and mortality in high-risk surgical patients.

How similar studies have gone: While previous studies have shown benefits of monitoring sedation and analgesia in major abdominal surgeries, this specific approach has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients affiliated to the French Social Security;
* informed and signed consent to participating in the study;
* planned postoperative hospitalization \> 48 hours;
* patients over 75 years of age with at least one of the following postoperative risk factors:

  * ischemic coronary disease;
  * history of compensated or prior heart failure;
  * stroke;
  * significant arrhythmias: fibrillation or auricular flutter with ventricular response \> 100/minute, multiform QRS complex) or cardiac conduction abnormalities (trifascicular block, auriculoventricular block of the second or third degree);
  * peripheral vascular disease;
  * chronic obstructive pulmonary disease;
  * chronic respiratory failure;
  * renal insufficiency, defined by a creatinine \> 175 µmol.l-1 (2 mg.dl-1);
  * insulin therapy for diabetes;
  * active cancer;
  * chronic alcohol abuse;
  * dementia.
* elective or emergency high-risk surgery under general anesthesia with a combination of hypnotic and opioid, and intubation or placement of a supraglottic airway control device

Non inclusion criteria:

* Patients who meet one or more of the preoperative following criteria will not be included:
* acute heart failure or acute myocardial infarction;
* complete arrhythmia due to atrial fibrillation;
* acute respiratory failure or pneumonia;
* septic shock;
* acute stroke;
* cardiac surgery;
* open chest surgery;
* opioid free anesthesia;
* intraoperative ketamine at a dose \> 0.25 mg.kg-1; \> 0.25 mg/kg or or intravenous electric syringe
* lidocaine or dexmedetomidine by continuous infusion;
* refusal to participate in the study;
* patient under guardianship, conservatorship, or unable to understand the study.

Where it's running

  • Chu D'Amiens Picardie
    Amiens, France
    Recruiting
  • Clinique Victor Pauchet
    Amiens, France
    Recruiting
  • Polyclinique Bordeaux Nord Aquitaine
    Bordeaux, France
    Recruiting
  • Chu de Lille
    Lille, France
    Recruiting
  • Chu de Nimes
    Nîmes, France
    Recruiting
  • Hopital Bichat Claude Bernard
    Paris, France
    Recruiting
Show 14 more locations
  • Chu Lyon Sud
    Pierre-Bénite, France
    Recruiting
  • Chu de Poitiers
    Poitiers, France
    Recruiting
  • Chu St-Etienne
    Saint-Etienne, France
    Recruiting
  • Chu de Toulouse
    Toulouse, France
    Recruiting
  • Médipole Lyon Villeurbanne
    Villeurbanne, France
    Recruiting
  • Chru de Besancon
    Besançon, France
    Not yet recruiting
  • Hôpital de La Cavale Blanche
    Brest, France
    Not yet recruiting
  • Chu Clermont-Ferrand
    Clermont-Ferrand, France
    Not yet recruiting
  • Chu de Grenoble
    Grenoble, France
    Not yet recruiting
  • APHM - Centre Hôpital Marseille Nord
    Marseille, France
    Not yet recruiting
  • Chu de Nantes
    Nantes, France
    Not yet recruiting
  • Hôpital l'Archet
    Nice, France
    Not yet recruiting
  • Hôpital Saint Charles
    Saint-Dié, France
    Not yet recruiting
  • Institut Gustave Roussy
    Villejuif, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.